• Skip to primary navigation
  • Skip to main content
SRI logo
  • About
    • Press room
    • Our history
  • Expertise
    • Advanced imaging systems
    • Artificial intelligence
    • Biomedical R&D services
    • Biomedical sciences
    • Computer vision
    • Cyber & formal methods
    • Education and learning
    • Innovation strategy and policy
    • National security
    • Ocean & space
    • Quantum
    • QED-C
    • Robotics, sensors & devices
    • Speech & natural language
    • Video test & measurement
  • Ventures
  • NSIC
  • Careers
  • Contact
  • 日本支社
Search
Close
Chemistry, materials, & energy publications January 1, 2008

Synthesis and Biological Evaluation of Alpha- and Beta-6-Amido Derivatives of 17-Cyclopropylmethyl-3, 14 Beta-Dihydroxy-4, 5 Alpha-Epoxymorphinan: Potential Alcohol-Cessation Agents

Abstract

Substituted aryl and aliphatic amide analogues of 6-naltrexamine were synthesized and used to characterize the binding to and functional activity of human μ-, δ-, and κ-opioid receptors. Competition binding assays showed 11–25 and 27–31 bound to the μ (Ki = 0.05–1.2 nM) and κ (Ki = 0.06–2.4 nM) opioid receptors. Compounds 11–18 possessed significant binding affinity for the δ receptor (Ki = 0.8–12.4 nM). Functional assays showed several compounds acted as partial or full agonists of δ or κ receptors while retaining an antagonist profile at the μ receptor. Structure–activity relationship for aryl amides showed that potent compounds possessed lipophilic groups or substituents capable of hydrogen bonding. Metabolic stability studies showed that 11, 12, and 14 possessed considerable stability in the presence of rat, mouse, or human liver preparations. The ED50 of inhibition of 10% ethanol self-administration in trained rats, using operant techniques for 11, was 0.5 mg/kg.[…]

↓ Review online

Share this

How can we help?

Once you hit send…

We’ll match your inquiry to the person who can best help you.

Expect a response within 48 hours.

Career call to action image

Make your own mark.

Search jobs

Our work

Case studies

Publications

Timeline of innovation

Areas of expertise

Institute

Leadership

Press room

Media inquiries

Compliance

Careers

Job listings

Contact

SRI Ventures

Our locations

Headquarters

333 Ravenswood Ave
Menlo Park, CA 94025 USA

+1 (650) 859-2000

Subscribe to our newsletter


日本支社
SRI International
  • Contact us
  • Privacy Policy
  • Cookies
  • DMCA
  • Copyright © 2022 SRI International